Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Raleigh, NC
NPI: 1164944377Primary Practice Location
DUKE UNIVERSITY HOSPITAL
2301 Erwin Rd, Durham, NC
Primary Employer
Duke Health Integrated Practice, Inc.
dhip.dukehealth.org
HQ Phone
Get MBBS, FRACP, PHD David's Phone Numberphone_androidMobile
Get MBBS, FRACP, PHD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 17 | 38 |
Validation of DNA methylation biomarkers for diagnosis of acute lymphoblastic leukemia.
Authors: Chatterton, Zac, Burke, Daniel, Emslie, Kerry R, Craig, Jeffery M, Ng, Jane, Ashley, David M, Mechinaud, Francoise, Saffery, Richard, Wong, Nicholas C
Journal: Clin Chem
Publication Date: 2014-05-14
Evaluation of microRNA expression in patient bone marrow aspirate slides.
Authors: Jefford, Michael, Kinnane, Nicole, Howell, Paula, Nolte, Linda, Galetakis, Spiridoula, Bruce Mann, Gregory, Naccarella, Lucio, Lai-Kwon, Julia, Simons, Katherine, Avery, Sharon, Thompson, Kate, Ashley, David, Haskett, Martin, Davies, Elise, Whitfield, Kathryn
Journal: Asia Pac J Clin Oncol
Publication Date: 2015-08-06
Lead Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Intervention / Treatment: DRUG: Temozolomide, BIOLOGICAL: GM-CSF, BIOLOGICAL: Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, BIOLOGICAL: Tetanus-Diphtheria Toxoid (Td), BIOLOGICAL: 111-Indium-labeling of Cells for in vivo Trafficking Studies
Lead Sponsor: Istari Oncology, Inc.
Collaborators: Duke University
Intervention / Treatment: DRUG: Lomustine, BIOLOGICAL: lerapolturev
Lead Sponsor: Eric Thompson, M.D.
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI), Annias Immunotherapeutics, Inc.
Intervention / Treatment: DRUG: 5-day TMZ, DRUG: 21-day TMZ, BIOLOGICAL: PEP-CMV: Component A, DRUG: Tetanus-Diphtheria booster, DRUG: Tetanus Pre-Conditioning, BIOLOGICAL: PEP-CMV: Component B
